This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Osteogenesis imperfecta type II - perinatal lethal

Authoring team

Type II is the lethal neonatal form of osteogenesis imperfecta, characterised by multiple fractures that occur in utero. The neonate will have crumpled long bones and beaded ribs. There is poor ossification of the skull. The sclerae, like those found in the type I form, are blue.

Other features include:

  • micromelia
  • platyspondyly

Notes:

  • nearly all osteogenesis imperfecta (OI) cases are due to heterozygosity of dominant mutations in one or other of the two genes (COL1A1 and COL1A2) that encode for type I procollagen chains (1)
    • these type 1 procollagen chains form type I collagen, the major structural protein of the extracellular matrix of bone, skin and tendons
      • there have been more than 200 mutations identified so far
      • some mutations give rise to a qualitative type I collagen defect caused by a structural alteration of the collagen molecule. Other mutations maintain the synthesis of normal collagen, but in reduced quantity
        • mutations resulting in qualitative changes in type I collagen generally lead to the most severe forms of OI name
    • the broad clinical and biomolecular spectrum mean that any classification is unable to be complete or accurate - however it represents a practical tool for the clinician dealing with management of patients

Reference:

  1. Devogalaer JP. New uses of bisphosphonates: osteogenesis imperfecta. Curr Opin Pharmacol. 2002 Dec;2(6):748-53

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.